{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:13:06Z","timestamp":1761808386590},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10840-020-00822-x","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T06:02:33Z","timestamp":1594447353000},"page":"337-345","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin"],"prefix":"10.1007","volume":"59","author":[{"given":"Brian C","family":"Hsia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Greige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A","family":"Quiroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S","family":"Khokhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Daily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J","family":"Ferrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Krumerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,11]]},"reference":[{"key":"822_CR1","unstructured":"Center for Systems Science and Engineering at Johns Hopkins University. Coronavirus COVID-19 Dashboard by the Center for Systems Science and Engineering at Johns Hopkins University. https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"822_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533\u20134. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1.","journal-title":"Lancet Infect Dis"},{"key":"822_CR3","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/CM9.0000000000000824","volume":"133","author":"Y Deng","year":"2020","unstructured":"Deng Y, Liu W, Liu K, Fang YY, Shang J, Zhou L, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J. 2020;133:1261\u20137. https:\/\/doi.org\/10.1097\/CM9.0000000000000824.","journal-title":"Chin Med J"},{"issue":"1","key":"822_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.47102\/annals-acadmedsg.2019252","volume":"49","author":"KJ Goh","year":"2020","unstructured":"Goh KJ, Choong MC, Cheong EH, Kalimuddin S, Duu Wen S, Phua GC, et al. Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID-19 infection. Ann Acad Med Singap. 2020;49(1):1\u20139.","journal-title":"Ann Acad Med Singap"},{"key":"822_CR5","doi-asserted-by":"publisher","unstructured":"Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan. China Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa270.","DOI":"10.1093\/cid\/ciaa270"},{"key":"822_CR6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet."},{"key":"822_CR7","doi-asserted-by":"publisher","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China JAMA Intern Med. 2020. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994.","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"822_CR8","doi-asserted-by":"publisher","unstructured":"Haynes N, Cooper LA, Albert MA, Association of Black C. At the heart of the matter: unmasking and addressing COVID-19\u2019s toll on diverse populations. Circulation. 2020. doi:https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.048126.","DOI":"10.1161\/CIRCULATIONAHA.120.048126"},{"key":"822_CR9","volume-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 \u2014 COVID-NET, 14 states, march 1\u201330","author":"S Garg","year":"2020","unstructured":"Garg S, Kim L, Whitaker M, O\u2019Halloran A, Cummings C, Holstein R, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 \u2014 COVID-NET, 14 states, march 1\u201330. In: MMWR Morb Mortal Wkly Rep. Centers for Disease Control and Prevention; 2020. https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm6915e3.htm?s_cid=mm6915e3_w."},{"key":"822_CR10","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/jac\/dkaa114","volume":"75","author":"D Zhou","year":"2020","unstructured":"Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020;75:1667\u201370. https:\/\/doi.org\/10.1093\/jac\/dkaa114.","journal-title":"J Antimicrob Chemother"},{"key":"822_CR11","unstructured":"US Food & Drug Administration. FDA Drug Shortages. https:\/\/www.accessdata.fda.gov\/scripts\/drugshortages\/default.cfm. ."},{"key":"822_CR12","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1001\/jama.2020.9184","volume":"323","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, van Meijgaard J, Mehra MR, Joseph J, O\u2019Donnell CJ, Warraich HJ. Prescription fill patterns for commonly used drugs during the COVID-19 pandemic in the United States. JAMA. 2020;323:2524. https:\/\/doi.org\/10.1001\/jama.2020.9184.","journal-title":"JAMA."},{"issue":"2","key":"822_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/15563650500514558","volume":"44","author":"CY Chen","year":"2006","unstructured":"Chen CY, Wang FL, Lin CC. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol (Phila). 2006;44(2):173\u20135. https:\/\/doi.org\/10.1080\/15563650500514558.","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"822_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/0976-500X.110892","volume":"4","author":"SB Khobragade","year":"2013","unstructured":"Khobragade SB, Gupta P, Gurav P, Chaudhari G, Gatne MM, Shingatgeri VM. Assessment of proarrhythmic activity of chloroquine in in vivo and ex vivo rabbit models. J Pharmacol Pharmacother. 2013;4(2):116\u201324. https:\/\/doi.org\/10.4103\/0976-500X.110892.","journal-title":"J Pharmacol Pharmacother"},{"issue":"2","key":"822_CR15","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/j.ijcard.2007.04.055","volume":"127","author":"P Stas","year":"2008","unstructured":"Stas P, Faes D, Noyens P. Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine. Int J Cardiol. 2008;127(2):e80\u20132. https:\/\/doi.org\/10.1016\/j.ijcard.2007.04.055.","journal-title":"Int J Cardiol"},{"issue":"2","key":"822_CR16","first-page":"83","volume":"45","author":"MD Bustos","year":"1994","unstructured":"Bustos MD, Gay F, Diquet B, Thomare P, Warot D. The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects. Trop Med Parasitol. 1994;45(2):83\u20136.","journal-title":"Trop Med Parasitol"},{"key":"822_CR17","doi-asserted-by":"publisher","first-page":"1574806","DOI":"10.1155\/2018\/1574806","volume":"2018","author":"Y Choi","year":"2018","unstructured":"Choi Y, Lim HS, Chung D, Choi JG, Yoon D. Risk evaluation of azithromycin-induced QT prolongation in real-world practice. Biomed Res Int. 2018;2018:1574806\u20138. https:\/\/doi.org\/10.1155\/2018\/1574806.","journal-title":"Biomed Res Int"},{"issue":"4","key":"822_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12012-017-9401-7","volume":"17","author":"M Zhang","year":"2017","unstructured":"Zhang M, Xie M, Li S, Gao Y, Xue S, Huang H, et al. Electrophysiologic studies on the risks and potential mechanism underlying the proarrhythmic nature of azithromycin. Cardiovasc Toxicol. 2017;17(4):434\u201340. https:\/\/doi.org\/10.1007\/s12012-017-9401-7.","journal-title":"Cardiovasc Toxicol"},{"issue":"5","key":"822_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/0897190013516503","volume":"27","author":"NM Maisch","year":"2014","unstructured":"Maisch NM, Kochupurackal JG, Sin J. Azithromycin and the risk of cardiovascular complications. J Pharm Pract. 2014;27(5):496\u2013500. https:\/\/doi.org\/10.1177\/0897190013516503.","journal-title":"J Pharm Pract"},{"issue":"11","key":"822_CR20","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1177\/1060028013504905","volume":"47","author":"PA Howard","year":"2013","unstructured":"Howard PA. Azithromycin-induced proarrhythmia and cardiovascular death. Ann Pharmacother. 2013;47(11):1547\u201351. https:\/\/doi.org\/10.1177\/1060028013504905.","journal-title":"Ann Pharmacother"},{"key":"822_CR21","doi-asserted-by":"publisher","unstructured":"Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan. China JAMA Cardiol. 2020. https:\/\/doi.org\/10.1001\/jamacardio.2020.0950.","DOI":"10.1001\/jamacardio.2020.0950"},{"key":"822_CR22","doi-asserted-by":"publisher","unstructured":"Guidicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potential of possible pharmacotherapies for COVID-19 [published online ahead of print march 25, 2020]. Mayo Clin Proc doi:https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.024, 2020.","DOI":"10.1016\/j.mayocp.2020.03.024"},{"key":"822_CR23","doi-asserted-by":"publisher","first-page":"e906","DOI":"10.1161\/CIRCULATIONAHA.120.047521","volume":"141","author":"DM Roden","year":"2020","unstructured":"Roden DM, Harrington RA, Poppas A, Russo AM. Considerations for drug interactions on QTc in exploratory COVID-19 (coronavirus disease 2019) treatment. Circulation. 2020;141:e906\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047521.","journal-title":"Circulation."},{"key":"822_CR24","doi-asserted-by":"publisher","unstructured":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. https:\/\/doi.org\/10.1001\/jamacardio.2020.1017.","DOI":"10.1001\/jamacardio.2020.1017"},{"key":"822_CR25","doi-asserted-by":"publisher","unstructured":"Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa237.","DOI":"10.1093\/cid\/ciaa237"},{"issue":"7","key":"822_CR26","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"822_CR27","unstructured":"General Electric Healthcare. Marquette\u2122 12SL\u2122 ECG Analysis Program Physician\u2019s Guide 2036070\u2013006 Revision C, 2010. In: Company GE, editor.2012."},{"key":"822_CR28","doi-asserted-by":"publisher","first-page":"105938","DOI":"10.1016\/j.ijantimicag.2020.105938","volume":"105938","author":"CA Devaux","year":"2020","unstructured":"Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020;105938:105938. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105938.","journal-title":"Int J Antimicrob Agents"},{"key":"822_CR29","doi-asserted-by":"publisher","unstructured":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan. China. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa248.","DOI":"10.1093\/cid\/ciaa248"},{"issue":"7798","key":"822_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u20133. https:\/\/doi.org\/10.1038\/s41586-020-2012-7.","journal-title":"Nature."},{"issue":"3","key":"822_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269\u201371. https:\/\/doi.org\/10.1038\/s41422-020-0282-0.","journal-title":"Cell Res"},{"key":"822_CR32","doi-asserted-by":"publisher","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","volume":"105949","author":"P Gautret","year":"2020","unstructured":"Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;105949:105949. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105949.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"822_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","volume":"14","author":"J Gao","year":"2020","unstructured":"Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72\u20133. https:\/\/doi.org\/10.5582\/bst.2020.01047.","journal-title":"Biosci Trends"},{"key":"822_CR34","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","volume":"382","author":"J Geleris","year":"2020","unstructured":"Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;382:2411\u20138. https:\/\/doi.org\/10.1056\/NEJMoa2012410.","journal-title":"N Engl J Med"},{"key":"822_CR35","doi-asserted-by":"publisher","unstructured":"Chorin E, Dai M, Shulman E, Wadhwani L, Bar Cohen R, Barbhaiya C et al. The QT interval in patients with SARS-CoV-2 infection treated with hydroxychloroquine\/azithromycin. medRxiv. 2020:2020.04.02.20047050. doi:https:\/\/doi.org\/10.1101\/2020.04.02.20047050.","DOI":"10.1101\/2020.04.02.20047050"},{"key":"822_CR36","doi-asserted-by":"publisher","first-page":"e008662","DOI":"10.1161\/CIRCEP.120.008662","volume":"13","author":"M Saleh","year":"2020","unstructured":"Saleh M, Gabriels J, Chang D, Kim BS, Mansoor A, Mahmood E, et al. The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection. Circ Arrhythm Electrophysiol. 2020;13:e008662. https:\/\/doi.org\/10.1161\/CIRCEP.120.008662.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"822_CR37","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41591-020-0888-2","volume":"26","author":"E Chorin","year":"2020","unstructured":"Chorin E, Dai M, Shulman E, Wadhwani L, Bar-Cohen R, Barbhaiya C, et al. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Nat Med. 2020;26:808\u20139. https:\/\/doi.org\/10.1038\/s41591-020-0888-2.","journal-title":"Nat Med"},{"key":"822_CR38","doi-asserted-by":"publisher","unstructured":"Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, et al. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. https:\/\/doi.org\/10.1001\/jamacardio.2020.1834.","DOI":"10.1001\/jamacardio.2020.1834"},{"key":"822_CR39","unstructured":"United States Census Bureau. United States Census Bureau: QuickFacts Bronx County (Bronx Borough), New York. 2019. https:\/\/www.census.gov\/quickfacts\/fact\/table\/bronxcountybronxboroughnewyork\/PST045217. ."},{"key":"822_CR40","doi-asserted-by":"publisher","unstructured":"Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa415.","DOI":"10.1093\/cid\/ciaa415"},{"issue":"4","key":"822_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.mayocp.2013.01.013","volume":"88","author":"KH Haugaa","year":"2013","unstructured":"Haugaa KH, Bos JM, Tarrell RF, Morlan BW, Caraballo PJ, Ackerman MJ. Institution-wide QT alert system identifies patients with a high risk of mortality. Mayo Clin Proc. 2013;88(4):315\u201325. https:\/\/doi.org\/10.1016\/j.mayocp.2013.01.013.","journal-title":"Mayo Clin Proc"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-020-00822-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T23:57:35Z","timestamp":1625961455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-020-00822-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,11]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1007\/s10840-020-00822-x","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,11]]},"assertion":[{"value":"11 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Obtained from the Institutional Review Board at the Albert Einstein College of Medicine, Bronx, New York.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}